Containing penicillins or derivatives thereof, with a penicillanic acid structure, or streptomycins or their derivatives
Mixed medicaments containing penicillins or streptomycin derivatives
HSN 3003 10 00 (medicaments containing penicillins or streptomycin derivatives, not in retail packs) is subject to Central Drugs Standard Control Organisation (CDSCO) registration and import licensing under the Drugs and Cosmetics Act, as administered by the Drug Controller General of India (DCGI). The tariff line is Restricted under the ITC (HS) import policy administered by the Directorate General of Foreign Trade (DGFT), with import permitted only upon satisfaction of CDSCO registration and all applicable drug-import requirements.
- Registration certificate from CDSCO
- Import licence from CDSCO
- Certificate of Analysis from manufacturer
Procedural directions for customs clearance are issued by: Directorate General of Foreign Trade.
- 1Obtain a valid drug registration certificate (document code 101dc1) and an import licence for drugs (document code 9111dc) from the Central Drugs Standard Control Organisation before filing the bill of entry. Both documents must be uploaded in e-Sanchit; clearance will not be granted unless both are present and current.ITC (HS) import policy, CTI 3003 10 00 · Drugs and Cosmetics Act (DCGI requirements)
- 2Upload the Certificate of Analysis (document code 0010dc), Batch Release Certificate (document code 0030dc), and Label of Consignment (document code 0110dc) in e-Sanchit at the bill of entry stage. The proper officer is required to verify all five mandatory document codes before granting out-of-charge.CDSCO e-Sanchit document codes 0010dc, 0030dc, 0110dc, 101dc1, 9111dc · ITC (HS) Restricted-import policy
The error that most commonly delays consignments under this tariff line is submitting a registration certificate that covers the innovator formulation but not the specific multi-constituent bulk mixture being imported. Because HSN 3003 10 00 covers medicaments consisting of two or more mixed constituents not in retail packs, each distinct formulation must be independently registered with CDSCO; a registration for a downstream finished dosage form does not extend to the upstream bulk mixture, and a mismatched registration triggers detention and potential confiscation under the Drugs and Cosmetics Act.